We are Galapagos
A pioneering biotech company. We create value through science.
We pioneer for patients
In our pursuit to discover, develop and deliver innovative medicines, we go where no one has ever gone before.
We dare, we care
As a hands-on company, our success is built on a culture of continuous scientific exploration, risk-taking, and speed of action for the benefit of patients.
Act as pioneers
We don’t shy away from fundamental challenges.
Raise the bar
We like to challenge each other to push the limits in every decision we make.
We’re not afraid to fail, because a dead end can be changed into an opportunity.
Make it happen
We’re proud of our responsibility to pioneer for patients.
We deliver our discoveries to patients
We want to become one of the leading biotech companies in the world. Headquartered in Mechelen, Galapagos employs over 800 people across Belgium, The Netherlands, France, Italy, Spain, the UK, Switzerland, the US, and Croatia.
Our people make it happen
We all have a crucial part to play in something far greater. Individually, as teams and as a company, we’re driven to never give up, pushing back the boundaries of what we know and think is possible. Because we know we can create a bigger impact by working together.
Get to know Galapagos in numbers
we want to become a fully integrated biopharma company.
clinical studies. And very close to bringing our first medicine to market.
We’re growing fast. From 2015 to 2019, we increased our clinical studies from 8 to 40.
ago, we started as an adventurous start-up founded by our CEO Onno van de Stolpe. Since then, we turned into an established international biotech player.